Roche will publish its Sales for the 3rd Quarter of 2024 prior to the opening of the Swiss Stock Exchange on Wednesday, 23 October 2024. 07:00 CEST / 06:00 BST / 01:00 AM EDT / 10:00 PM PDT (evening before) Release will be e-mailed and posted on the Roche IR website > click here Presentation slides will be posted on the Roche IR website > click here 14:00 – 15:30 CEST / 13:00 – 14:30 BST 08:00 – 09:30 AM EDT / 05:00 - 06:30 AM PDT The webinar will start with presentations by senior management, followed by a Q&A session. Presenters: Thomas Schinecker, CEO Roche Group Alan Hippe, Chief Financial and IT Officer Roche Teresa Graham, CEO Roche Pharmaceuticals Matt Sause, CEO Roche Diagnostics  We would like to invite all interested parties to participate in the webinar and to pre-register for the event here.* Should you be unable to register for the webinar due to your company IT policy, please send an email to investor.relations@roche.com. A replay of the webinar will be available via > ir.roche.com *privacy notice Best regards,
Bruno Eschli Head of Investor Relations

 

Roche Investor Relations
Dr. Bruno Eschli Phone: +41 61 68-75284 e-mail: bruno.eschli@roche.com	Dr. Sabine Borngräber Phone: +41 61 68-88027 e-mail: sabine.borngraeber@roche.com
Dr. Birgit Masjost Phone: +41 61 68-84814 e-mail: birgit.masjost@roche.com
Investor Relations North America
Loren Kalm Phone: +1 650 225 3217 e-mail: kalm.loren@gene.com

get the latest news and updates to your inbox.